PRESS RELEASE published on 09/13/2023 at 14:30, 2 years 11 months ago Patent Issued in Japan Bolsters IP Protection for Jaguar Health in the Treatment of Short Bowel Syndrome (SBS)
PRESS RELEASE published on 09/12/2023 at 14:30, 2 years 11 months ago Napo Pharmaceuticals, a Jaguar Health Family Company, Submits Funding Application to National Institute of Allergy and Infectious Diseases for Development of NP-300 Drug Candidate for Cholera-Related Diarrhea
PRESS RELEASE published on 09/11/2023 at 14:30, 2 years 11 months ago Jaguar Health Shares Replay Link for September 7, 2023 Presentation at Emerging Growth Conference
PRESS RELEASE published on 09/07/2023 at 14:30, 2 years 11 months ago Jaguar Health's Executive VP Dr. Karen Brunke Joins BIO's Rare Disease and Orphan Drugs Committee
PRESS RELEASE published on 08/30/2023 at 14:30, 3 years ago The Science Times Publishes Article About Jaguar Health's Focus on Developing Crofelemer for Two Rare Disease Indications
PRESS RELEASE published on 08/28/2023 at 14:30, 3 years ago Jaguar Health to Present September 7 at Emerging Growth Conference and at the September 11-13 H.C. Wainwright Annual Global Investment Conference
PRESS RELEASE published on 08/24/2023 at 13:00, 3 years ago Jaguar Health Engages B2i Digital to Deploy Cutting-Edge Investor Engagement Campaign
PRESS RELEASE published on 08/17/2023 at 14:30, 3 years ago Napo Pharmaceuticals, a Jaguar Health Family Company, Reports Completion of Last Patient Last Visit for its Pivotal Phase 3 OnTarget Trial of Crofelemer for Preventive Treatment of Cancer Therapy-Related Diarrhea
PRESS RELEASE published on 08/16/2023 at 14:30, 3 years ago Napo Pharmaceuticals Surveys of Neurologists, Patients, and Caregivers Regarding Amyotrophic Lateral Sclerosis (ALS) Treatment Indicate Real World Burden of Diarrhea and Potential Treatment Interruption
PRESS RELEASE published on 08/14/2023 at 14:00, 3 years ago Jaguar Health Reports Second Quarter 2023 Financial Results
Published on 09/01/2026 at 16:10, 5 hours 45 minutes ago Sparton Signs Definitive Morrison Silver Mine Option and Joint Venture Agreement with Glen Eagle; Appoints Vice President, Corporate Development
Published on 09/01/2026 at 15:40, 6 hours 15 minutes ago Norsemont Provides Choquelimpie Drilling Update
Published on 09/01/2026 at 15:30, 6 hours 25 minutes ago Caldwell Launches Global Financial Institutions Group Practice
Published on 09/01/2026 at 14:31, 7 hours 24 minutes ago First Breach Expands Ammunition Manufacturing Capacity with Installation of New Loading and Inspection Equipment
Published on 09/01/2026 at 20:07, 1 hour 48 minutes ago EQS-Adhoc: HUGO BOSS AG: HUGO BOSS TERMINATES SHARE BUYBACK PROGRAM
Published on 09/01/2026 at 20:00, 1 hour 55 minutes ago MHM Corporate: announces the launch of a capital increase with preferential subscription rights for a maximum amount of approximately €1.1 million
Published on 09/01/2026 at 18:01, 3 hours 54 minutes ago Gerresheimer AG: Annual General Meeting Approves the Company's Proposed Resolutions by a Majority Vote
Published on 09/01/2026 at 19:00, 2 hours 55 minutes ago Covivio - Information on total number of voting rights and share capital
Published on 09/01/2026 at 18:18, 3 hours 37 minutes ago TF1 - Monthly disclosure of the total number of shares and voting rights - August 2026
Published on 09/01/2026 at 17:44, 4 hours 11 minutes ago Reporting on share buyback transactions carried out between August 18 and August 28, 2026
Published on 09/01/2026 at 17:39, 4 hours 16 minutes ago Disclosure of transactions in own shares of 31 August, 2026
Published on 08/31/2026 at 17:45, 1 day 4 hours ago Disclosure of transactions in own shares from August 24 to August 28, 2026
